Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,037.00    38.40 (3.85%)
Bid:
1,037.00
Ask:
1,038.00
Spread: 1.00 (0.096%)
Market Cap: £3.33b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Director/PDMR Shareholding

17 Oct 2019 14:39

RNS Number : 2798Q
Persimmon PLC
17 October 2019
 

17 October 2019

Persimmon Plc (the "Company")

 

Director/PDMR Shareholding

 

 

On 15 October 2019, Dave Jenkinson, Group Chief Executive, exercised an award under the Company's 2012 Long Term Incentive Plan ("2012 LTIP").

Dave Jenkinson received 217,874 shares, net of income tax and national insurance liabilities.

Dave Jenkinson has not sold any of the shares received.

Under the rules of the 2012 LTIP Dave Jenkinson is required to hold 50% of the shares received for at least twelve months. Consequently, Dave Jenkinson will hold a minimum of 108,937 of these shares until at least 15 October 2020.

 

Following this transaction the total interests in the Company of Dave Jenkinson and his Closely Associated Persons have increased to 781,124 shares.

 

The below notification, made in accordance with the requirements of article 19.3 of the EU Market Abuse Regulation, give further details:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

 

a)

 

Name

Dave Jenkinson

 

2

 

Reason for the notification

 

 

a)

 

Position/status

 

Group Chief Executive

 

b)

 

Initial notification /Amendment

 

Initial notification

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

 

Name

 

Persimmon Plc

 

b)

 

LEI

 

213800XI72Y57UWN6F31

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

Transaction 1

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

 

 

Identification code

GB0006825383

 

 

b)

 

Nature of the transaction

 

 

Acquisition of shares pursuant to the exercise of an option under the Persimmon Plc 2012 Long Term Incentive Plan

 

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

Nil

411,084

 

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

N/A Single transaction

 

 

- Price

N/A Single transaction

 

 

e)

 

Date of the transaction

 

15/10/2019

 

f)

 

Place of the transaction

 

Outside of a main market

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Transaction 2

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

 

 

 

Identification code

GB0006825383

 

 

b)

 

Nature of the transaction

 

 

Transfer to the company's employee benefit trust of shares acquired pursuant to the exercise of an option under the 2012 LTIP in satisfaction of the tax liability arising on the exercise.

 

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

£23.80

193,210

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

N/A Single transaction

 

 

- Price

N/A Single transaction

 

 

e)

 

Date of the transaction

 

15/10/2019

 

f)

 

Place of the transaction

 

Outside of a main market

 

 

 

Tracy Davison

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEADEXFDKNFFF
Date   Source Headline
1st May 20252:20 pmRNSResult of AGM
1st May 20252:02 pmRNSTotal Voting Rights
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.